cbdc central bank digital currency Knowledge

Onlikon: Compound α-keto acid tablets are planned to be selected for the tenth batch of national centralized drug procurement. Onlikon announced on December 13, and on December 12, the company participated in the bidding for the tenth batch of national centralized drug procurement organized by the National Drug Joint Procurement Office. After the bid opening and evaluation by the Joint Procurement Office, the company plans to select this centralized drug procurement. The indication of that medicine is to prevent and treat the damage caused by metabolic disorder in protein due to chronic renal insufficiency. The drug is a national medical insurance catalogue product, with an annual sales of 218,900 yuan in 2023, accounting for 0.01% of the company's annual operating income in 2023.Apple is reported to cooperate with Broadcom to develop AI chips, and TSMC's advanced process will welcome big orders again. On December 13, it was reported that Apple intends to invest in self-developed AI chips, jointly develop them with Broadcom, and produce them in TSMC's 3 nm process, and mass-produce them in 2026. The legal person is optimistic that after the development of Apple's self-developed AI chip is completed, the investment is expected, and TSMC's advanced process will usher in another big order. It is understood that Apple's current A-series processors for iPhone and M-series processors for Mac all adopt self-developed strategies, and are exclusively manufactured by TSMC. The legal person believes that once Apple's self-developed chips are extended to AI chips, the cooperation with TSMC will be closer. (Taiwan Province Economic Daily)A spokesman for UnitedHealth Group said that the mother of Mangione, a suspect accused of shooting a company executive, also had no insurance for UnitedHealth.

Morgan Stanley called concerns about South Korean financial stocks "excessive". Morgan Stanley said that recent political developments have hit South Korean financial stocks particularly hard because people are worried that reform efforts may be delayed and the risk of tightening supervision.Bank of Japan: The index of small non-manufacturers rose for the second consecutive quarter, reaching the highest level since August 1991.Full-page observation of People's Daily: Accelerate the construction of world-class universities and advantageous disciplines with China characteristics.

US Congressman French Hill will take over as the chairman of the House Financial Services Committee. On December 12, local time, the reporter learned that French Hill, a Republican congressman and former banker from Arkansas, will be the next chairman of the House Financial Services Committee. The Financial Services Committee of the House of Representatives is an important body of the US Congress, which is responsible for supervising the financial industry and formulating relevant legislation. Its responsibilities cover banking, the overall financial system and the cryptocurrency market. Hill will succeed retiring Patrick Patrick McHenry, whose formal appointment is expected to be approved by the Republican Party in the next few days. (CCTV)Google released the Android XR operating system, and Samsung's first launch will be launched next year. On December 12, local time, Google launched a new operating system Android XR developed in cooperation with Samsung, which combines years of investment in AI, AR and VR, aiming at wearing devices and smart glasses. Bring a practical experience. This release is a preview for developers, who can start to develop applications and games for the upcoming Android XR device. The first head-mounted display device developed based on Android XR is code-named "Project Moohan", which is made by Samsung and will go on sale next year.Onlikon: Compound α-keto acid tablets are planned to be selected for the tenth batch of national centralized drug procurement. Onlikon announced on December 13, and on December 12, the company participated in the bidding for the tenth batch of national centralized drug procurement organized by the National Drug Joint Procurement Office. After the bid opening and evaluation by the Joint Procurement Office, the company plans to select this centralized drug procurement. The indication of that medicine is to prevent and treat the damage caused by metabolic disorder in protein due to chronic renal insufficiency. The drug is a national medical insurance catalogue product, with an annual sales of 218,900 yuan in 2023, accounting for 0.01% of the company's annual operating income in 2023.